Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Cyclosporine combination therapy can regrow hair in severe alopecia areata but needs careful monitoring for side effects.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Rosacea is a skin condition with unclear causes, classified into four subtypes.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

New effective scar treatments are urgently needed due to the current options' limited success.

Current treatments for alopecia show no significant long-term benefits.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

Liposomes could improve how skin care products work but are costly and not very stable.